2-iodomelatonin has been researched along with cetrorelix in 1 studies
| Studies (2-iodomelatonin) | Trials (2-iodomelatonin) | Recent Studies (post-2010) (2-iodomelatonin) | Studies (cetrorelix) | Trials (cetrorelix) | Recent Studies (post-2010) (cetrorelix) |
|---|---|---|---|---|---|
| 245 | 0 | 10 | 609 | 157 | 157 |
| Protein | Taxonomy | 2-iodomelatonin (IC50) | cetrorelix (IC50) |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | Homo sapiens (human) | 0.0042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Kato, M; Sakuma, Y; Sato, S; Yin, C | 1 |
1 other study(ies) available for 2-iodomelatonin and cetrorelix
| Article | Year |
|---|---|
Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
Topics: Animals; Cell Line; Cell Line, Tumor; Central Nervous System Depressants; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Melatonin; Membrane Potentials; Mice; Neurons; NIH 3T3 Cells; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, GABA-A; Receptors, LHRH; RNA, Messenger; Time Factors | 2009 |